Prevention and treatment of Staphylococcus aureus pneumonia with a β-cyclodextrin derivative

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 1, 2010, Pages 298-304

  Ragle, Brook E ^a   Karginov, Vladimir A ^b   Wardenburg, Juliane Bubeck ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b Innovative Biologics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; BETA CYCLODEXTRIN DERIVATIVE; CYTOTOXIN; IB 201; METICILLIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL SURFACE; CONTROLLED STUDY; DRUG SAFETY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; MORTALITY; MOUSE; NONHUMAN; OLIGOMERIZATION; PATHOGENESIS; PRIORITY JOURNAL; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS;

ANIMALS; BETA-CYCLODEXTRINS; CELL LINE; CELL SURVIVAL; ERYTHROCYTES; HEMOLYSIN PROTEINS; HEMOLYSIS; LUNG; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED C57BL; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, STAPHYLOCOCCAL; RABBITS; STAPHYLOCOCCUS AUREUS;

EID: 73849113321     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00973-09     Document Type: Article

References (35)

1. Athanassa, Z., I. I. Siempos, and M. E. Falagas. 2008. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur. Respir. J. 31:625-632.
2. Bhakdi, S., and J. Tranum-Jensen. 1991. Alpha-toxin of Staphylococcus aureus. Microbiol. Rev. 55:733-751.
3. Bramley, A. J., A. H. Patel, M. O'Reilly, R. Foster, and T. J. Foster. 1989. Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect. Immun. 57:2489-2494.
4. Bubeck Wardenburg, J., T. Bae, M. Otto, F. R. DeLeo, and O. Schneewind. 2007. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat. Med. 13:1405-1406.
5. Bubeck Wardenburg, J., R. J. Patel, and O. Schneewind. 2007. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect. Immun. 75:1040-1044.
6. Bubeck Wardenburg, J., and O. Schneewind. 2008. Vaccine protection against Staphylococcus aureus pneumonia. J. Exp. Med. 205:287-294.
7. Callegan, M. C., L. S. Engel, J. M. Hill, and R. J. O'Callaghan. 1994. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis. Infect. Immun. 62:2478-2482.
8. Finelli, L., A. Fiore, R. Dhara, L. Brammer, D. K. Shay, L. Kamimoto, A. Fry, J. Hageman, R. Gorwitz, J. Bresee, and T. Uyeki. 2008. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics 122:805-811.
9. Frazee, B. W. 2007. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. Ann. Emerg. Med. 50:612-616.
10. Fridkin, S. K., J. C. Hageman, M. Morrison, L. T. Sanza, K. Como-Sabetti, J. A. Jernigan, K. Harriman, L. H. Harrison, R. Lynfield, and M. M. Farley. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 352:1436-1444.
11. Gouaux, E., M. Hobaugh, and L. Song. 1997. Alpha-hemolysin, gammahemolysin, and leukocidin from Staphylococcus aureus: distant in sequence but similar in structure. Protein Sci. 6:2631-2635.
12. Gu, L. Q., and H. Bayley. 2000. Interaction of the noncovalent molecular adapter, beta-cyclodextrin, with the staphylococcal alpha-hemolysin pore. Biophys. J. 79:1967-1975.
13. Gu, L. Q., O. Braha, S. Conlan, S. Cheley, and H. Bayley. 1999. Stochastic sensing of organic analytes by a pore-forming protein containing a molecular adapter. Nature 398:686-690.
14. Hidron, A. I., J. R. Edwards, J. Patel, T. C. Horan, D. M. Sievert, D. A. Pollock, and S. K. Fridkin for the National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities. 2008. Antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29:996-1011.
15. Kallen, A. J., J. Brunkard, Z. Moore, P. Budge, K. E. Arnold, G. Fosheim, L. Finelli, S. E. Beekmann, P. M. Polgreen, R. Gorwitz, and J. Hageman. 2009. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann. Emerg. Med. 53:358-365.
16. Karginov, V. A., E. M. Nestorovich, F. Schmidtmann, T. M. Robinson, A. Yohannes, N. E. Fahmi, S. M. Bezrukov, and S. M. Hecht. 2007. Inhibition of S. aureus alpha-hemolysin and B. anthracis lethal toxin by beta-cyclodextrin derivatives. Bioorg. Med. Chem. 15:5424-5431.
17. Kawate, T., and E. Gouaux. 2003. Arresting and releasing staphylococcal alpha-hemolysin at intermediate stages of pore formation by engineered disulfide bonds. Protein Sci. 12:997-1006.
18. Klevens, R. M., M. A. Morrison, J. Nadle, S. Petit, K. Gershman, S. Ray, L. H. Harrison, R. Lynfield, G. Dumyati, J. M. Townes, A. S. Craig, E. R. Zell, G. E. Fosheim, L. K. McDougal, R. B. Carey, and S. K. Fridkin. 2007. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298:1763-1771.
19. Kollef, M. H., A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, and R. S. Johannes. 2005. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128:3854-3862.
20. Kuehnert, M. J., H. A. Hill, B. A. Kupronis, J. I. Tokars, S. L. Solomon, and D. B. Jernigan. 2005. Methicillin-resistant Staphylococcus aureus hospitalizations, United States. Emerg. Infect. Dis. 11:868-872.
21. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
22. McCormick, C. C., A. R. Caballero, C. L. Balzli, A. Tang, and R. J. O'Callaghan. 2009. Chemical inhibition of alpha-toxin, a key corneal virulence factor of Staphylococcus aureus. Invest. Ophthalmol. Vis. Sci. 50:2848-2854.
23. McElroy, M. C., H. R. Harty, G. E. Hosford, G. M. Boylan, J. F. Pittet, and T. J. Foster. 1999. Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect. Immun. 67:5541-5544.
24. McNiven, A. C., P. Owen, and J. P. Arbuthnott. 1972. Multiple forms of staphylococcal alpha-toxin. J. Med. Microbiol. 5:113-122.
25. Menzies, B. E., and D. S. Kernodle. 1994. Site-directed mutagenesis of the alpha-toxin gene of Staphylococcus aureus: role of histidines in toxin activity in vitro and in a murine model. Infect. Immun. 62:1843-1847.
26. O'Reilly, M., J. C. de Azavedo, S. Kennedy, and T. J. Foster. 1986. Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb. Pathog. 1:125-138.
27. Patel, A. H., P. Nowlan, E. D. Weavers, and T. Foster. 1987. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect. Immun. 55:3103-3110.
28. Ragle, B. E., and J. Bubeck Wardenburg. 2009. Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun. 77:2712-2718.
29. Rose, F., G. Dahlem, B. Guthmann, F. Grimminger, U. Maus, J. Hanze, N. Duemmer, U. Grandel, W. Seeger, and H. A. Ghofrani. 2002. Mediator generation and signaling events in alveolar epithelial cells attacked by S. aureus alpha-toxin. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:L207-L214.
30. Rubin, R. J., C. A. Harrington, A. Poon, K. Dietrich, J. A. Greene, and A. Moiduddin. 1999. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg. Infect. Dis. 5:9-17.
31. Seeger, W., M. Bauer, and S. Bhakdi. 1984. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium. J. Clin. Invest. 74:849-858.
32. Seeger, W., R. G. Birkemeyer, L. Ermert, N. Suttorp, S. Bhakdi, and H. R. Duncker. 1990. Staphylococcal alpha-toxin-induced vascular leakage in isolated perfused rabbit lungs. Lab. Invest. 63:341-349.
33. Song, L., M. R. Hobaugh, C. Shustak, S. Cheley, H. Bayley, and J. E. Gouaux. 1996. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274:1859-1866.
34. Walker, B., and H. Bayley. 1995. Key residues for membrane binding, oligomerization, and pore forming activity of staphylococcal alpha-hemolysin identified by cysteine scanning mutagenesis and targeted chemical modification. J. Biol. Chem. 270:23065-23071.
35. Walker, B., and H. Bayley. 1995. Restoration of pore-forming activity in staphylococcal alpha-hemolysin by targeted covalent modification. Protein Eng. 8:491-495.